The second innovation, Teamplay Mammo Dashboard, is a dashboard running on the Siemens Healthineers Teamplay Digital Health Platform that was specifically designed for breast care centers. Teamplay Mammo Dashboard provides an intuitive overview of specific institution, modality, and examination KPIs to reveal potential workflow optimizations. The KPIs tracked include radiation dose, device utilization, and other parameters, making important steps of the mammography examination process transparent while identifying possible bottlenecks. This enables institutions to increase workflow efficiency and standardization in imaging. With this newest addition to the Teamplay performance management applications based on the Teamplay Digital Health Platform, Siemens Healthineers continues to streamline operations unlocking potential productivity gains, making the most of the data acquired and providing tangible recommendations for improvements.
About Siemens Healthineers AGSiemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.
1. Next-Gen AI is an option and available with Transpara® powered by FusionAI™, ScreenPointMedical.
2. Using AI to triage which screening mammograms benefit from a double reading strategy. C Balta, PhD, Nijmegen, Netherlands; A Rodriguez-Ruiz; C Mieskes; N Karssemeijer, PhD; S H Heywang-Koebrunner, MD. RSNA 2020